Clinical Trial Update: First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial update reports results for a first-line metastatic colorectal cancer therapy used in combination with the FOLFOX regimen; status show…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Colorectal Cancer | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2012-11-28